Merrimack Pharmaceuticals
#7923
Rank
$223.75M
Marketcap
United States
Country
Dr. Ulrik B. Nielsen Ph.D. (Co-Founder & Independent Director)
Mr. Gary L. Crocker M.B.A., MBA (Pres, Treasurer, Principal Financial Officer, Principal Accounting Officer, CEO & Chairman)
Dr. Anthony J. Sinskey Ph.D., Sc.D. (Co-Founder and Scientific Advisor)
Summary
History
Merrimack was founded in 2000 and went public in 2007. Merrimack's headquarters are located in Cambridge, MA. Merrimack is focused on discovering, developing and preparing to commercialize innovative medicines paired with diagnostics for the treatment of cancer. In 2015, Merrimack refocused its strategy and operations exclusively on the research, development and commercialization of oncology medicines.
Mission
Vision
Key Team
Geoffrey Grande C.F.A. (Sr. Director of Communications)
Ms. Ellen K. Forest (Head of HR)
Dr. Daryl C. Drummond Ph.D. (Head of Research)
Dr. Fazal R. Khan Ph.D. (Sr. VP of Manufacturing)
Mr. Timothy R. Surgenor (Sec.)
Recognition and Awards
References
https://en.wikipedia.org/wiki/Merrimack_Pharmaceuticals
https://in.investing.com/equities/merrimack-pharmaceuticals-inc
https://finance.yahoo.com/quote/MACK/profile?p=MACK
https://www.comparably.com/companies/merrimack-pharmaceuticals/mission
https://www.crunchbase.com/organization/merrimack-pharmaceuticals
Dive deeper into fresh insights across Business, Industry Leaders and Influencers, Organizations, Education, and Investors for a comprehensive view.
Dr. Ulrik B. Nielsen Ph.D. (Co-Founder & Independent Director)
Mr. Gary L. Crocker M.B.A., MBA (Pres, Treasurer, Principal Financial Officer, Principal Accounting Officer, CEO & Chairman)
Dr. Anthony J. Sinskey Ph.D., Sc.D. (Co-Founder and Scientific Advisor)